Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

REMICADE® (infliximab)

Medical Information

+ Save link

REMICADE - Latex Content

Last Updated: 11/21/2024

SUMMARY

REMICADE 100 mg Lyophilized Powder for Intravenous (IV) Infusion in Vials

No latex (natural rubber) is present in the immediate container or excipients of REMICADE 100 mg lyophilized powder for IV infusion in vials. The immediate container and excipients are not made with natural rubber latex, but cannot guarantee that the immediate container and excipients do not come in contact with latex during the manufacturing or packaging process (eg, latex gloves).¹

References

Show

1	Data on File. Technical Document Patient Safety and Compliance Information of REMICADE (infliximab) 100 mg lyophilized powder for intravenous (IV) infusion in vials v2. Janssen Research and Development, LLC; 2022.